Course Launch Announcement: Tailoring Approaches to Management in Patients with Rheumatoid Arthritis: What’s New?
Target audience: Rheumatologists
The most recent update to the 2015 American College of Rheumatology (ACR) guidelines recommends treating to a target of remission in rheumatoid arthritis (RA), if possible. In support of these goals, a number of clinical trials have demonstrated the effectiveness of early intensive therapy and tight control in providing RA patients with the best clinical outcomes, especially in those with early disease. However, these disease management strategies are not being optimally implemented, especially regarding the use of the ACR-recommended disease activity measures, the application of treat-to-target recommendations, and the implementation of the ACR-endorsed RA quality measures. This may negatively impact outcomes for patients who are not responding adequately to their prescribed treatments. Moreover, there are new data demonstrating efficacy of emerging targeted therapies, including IL-6 directed therapies in RA and clinicians need to be aware of these.
This multi-activity CME curriculum is designed to be directed to your needs. The initial activity is interactive and fast-paced. It allows you to test your knowledge and practice through a series of case vignettes. Compare yourself to your peers and find out what the experts have to say about RA. Once you have completed the activity, you will be directed to other activities in RA that may be of interest.
This activity, Tailoring Approaches to Management in Patients with Rheumatoid Arthritis, offers 1.00 AMA PRA Category 1 Credit(s)™, and is available at: http://realcme.com/cms/node/754020.